Hyery Kim
Overview
Explore the profile of Hyery Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
94
Citations
427
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Jang J, Park J, Kim Y, Im H, Koh K, Kim H, et al.
Turk J Pediatr
. 2024 Mar;
66(1):99-109.
PMID: 38523384
Background: Intensive multimodal treatment can improve survival in patients with high-risk neuroblastoma, and consolidative radiation therapy has contributed to local control. We examined the clinical outcomes of patients who underwent...
12.
Hwang S, Lee Y, Yoon J, Kim J, Kim H, Koh K, et al.
Ann Pediatr Endocrinol Metab
. 2024 Jan;
29(2):109-118.
PMID: 38271994
Purpose: As the survival rate from pediatric cancers has increased significantly with advances in treatment modalities, long-term endocrine complications have also risen. This study investigated the frequencies and risks of...
13.
Seo E, Choi E, Kim J, Kim H, Koh K, Im H, et al.
PLoS One
. 2023 Nov;
18(11):e0294486.
PMID: 37956185
[This corrects the article DOI: 10.1371/journal.pone.0246191.].
14.
Kim H, Kim H, Jo Y, Yoon S, Koh Y, Kang S, et al.
Cancer Res Treat
. 2023 Sep;
56(1):294-304.
PMID: 37680122
Purpose: We aimed to determine the current application and survival trends of hematopoietic stem cell transplantation (HSCT) among Korean children and adolescents with cancer. Materials And Methods: Data of patients...
15.
Kim H, Kim H, Kang S, Koh K, Im H, Park Y
JMIR Public Health Surveill
. 2023 Feb;
9:e41203.
PMID: 36754630
Background: Childhood cancer has a high long-term morbidity and mortality rate. Five years after the initial cancer diagnosis, approximately two-thirds of childhood cancer survivors experience at least one late complication,...
16.
Kang S, Kim W, Lee J, Suh J, Kim H, Kim D, et al.
Pediatr Blood Cancer
. 2023 Feb;
70(4):e30233.
PMID: 36751119
Background: Patients with relapsed osteosarcoma have poor treatment outcomes. High-dose chemotherapy with autologous stem cell transplantation (HDCT/ASCT) has been used in several high-risk malignant solid tumors; however, few studies have...
17.
Koh K, Han J, Choi H, Kang H, Lee J, Yoo K, et al.
Cancer Res Treat
. 2022 Aug;
55(1):279-290.
PMID: 35952715
Purpose: Renal tumors account for approximately 7% of all childhood cancers. These include Wilms tumor (WT), clear cell sarcoma of the kidney (CCSK), malignant rhabdoid tumor of the kidney (MRTK),...
18.
Suh J, Koh Y, Kang S, Kim H, Choi E, Koh K, et al.
Blood Res
. 2022 Jun;
57(2):152-157.
PMID: 35678159
Background: The incorporation of a reduced-intensity conditioning (RIC) regimen in hematopoietic cell transplantation (HCT) for patients with hemophagocytic lymphohistiocytosis (HLH) has decreased early mortality but is associated with a high...
19.
Jeon W, Koh Y, Kang S, Kim H, Koh K, Im H
Blood Res
. 2022 Mar;
57(1):41-50.
PMID: 35256548
Background: Aggressive mature B-cell non-Hodgkin lymphoma (B-NHL) is the most common non-Hodgkin lymphoma in children. The outcome of chemotherapy for B-NHL has improved over decades. Methods: We reviewed 82 children...
20.
Suh J, Im H, Kang S, Kim H, Choi E, Koh K
Bone Marrow Transplant
. 2022 Feb;
57(4):681-684.
PMID: 35132202
No abstract available.